In the US, Matzim LA (diltiazem systemic) is a member of the following drug classes: calcium channel blocking agents, group IV antiarrhythmics and is used to treat Angina Pectoris Prophylaxis, Atrial Fibrillation, Atrial Flutter, Heart Failure, High Blood Pressure, Raynaud's Syndrome and Supraventricular Tachycardia.
Ingredient matches for Matzim LA
Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Matzim LA in the following countries:
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.